Find Bupropion Hydrobromide manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

KDMF

KDMF

0

VMF

NDC API

API REF. PRICE (USD/KG)

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF DossiersDRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

JP

PATENTS & EXCLUSIVITIES

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

GLOBAL SALES INFORMATION

US Medicaid

NA

77 RELATED EXCIPIENT COMPANIES

138EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 905818-69-1, Aplenzin, Bupropion hbr, Bupropion hydrobromide [usan], Bupropion (hydrobromide), 2-(tert-butylamino)-1-(3-chlorophenyl)propan-1-one hydrobromide
Molecular Formula
C13H19BrClNO
Molecular Weight
320.65  g/mol
InChI Key
WSTCENNATOVXKQ-UHFFFAOYSA-N
FDA UNII
E70G3G5863

Bupropion Hydrobromide
Bupropion Hydrobromide is the hydrobromide salt of an aminoketone with antidepressant activity. The molecular mechanism of the antidepressant effect of bupropion is unknown. This agent does not inhibit monoamine oxidase and, compared to classical tricyclic antidepressants, is a weak blocker of the neuronal uptake of serotonin and norepinephrine. Buproprion also weakly inhibits the neuronal re-uptake of dopamine.
1 2D Structure

Bupropion Hydrobromide

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
2-(tert-butylamino)-1-(3-chlorophenyl)propan-1-one;hydrobromide
2.1.2 InChI
InChI=1S/C13H18ClNO.BrH/c1-9(15-13(2,3)4)12(16)10-6-5-7-11(14)8-10;/h5-9,15H,1-4H3;1H
2.1.3 InChI Key
WSTCENNATOVXKQ-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C.Br
2.2 Other Identifiers
2.2.1 UNII
E70G3G5863
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. 905818-69-1

2. Aplenzin

3. Bupropion Hbr

4. Bupropion Hydrobromide [usan]

5. Bupropion (hydrobromide)

6. 2-(tert-butylamino)-1-(3-chlorophenyl)propan-1-one Hydrobromide

7. Bvf-033

8. E70g3g5863

9. Bupropion Hydrobromide (usan)

10. Aplenzin Er

11. Unii-e70g3g5863

12. Aplenzin (tn)

13. Schembl636116

14. Chembl1201735

15. Dtxsid20920317

16. Bupropion Hydrobromide [mi]

17. 2-(tert-butylamino)-1-(3-chlorophenyl)propan-1-one,hydrobromide

18. 2-(tert-butylamino)-1-(3-chlorophenyl)propan-1-one;hydrobromide

19. Bupropion Hydrobromide [vandf]

20. Akos015917698

21. Bupropion Hydrobromide [mart.]

22. Bupropion Hydrobromide [usp-rs]

23. Bupropion Hydrobromide [who-dd]

24. Bupropion Hydrobromide [orange Book]

25. D07938

26. Q27276951

27. (2rs)-1-(3-chlorophenyl)-2-((1,1-dimethylethyl)amino)propan-1-one Hbr

28. (2rs)-1-(3-chlorophenyl)-2-((1,1-dimethylethyl)amino)propan-1-one Hydrobromide

29. 1-propanone, 1-(3-chlorophenyl)-2-((1,1-dimethylethyl)amino)-, Hbr (1:1)

30. 1-propanone, 1-(3-chlorophenyl)-2-((1,1-dimethylethyl)amino)-, Hydrobromide (1:1)

31. 2-(tert-butylamino)-1-(3-chlorophenyl)propan-1-one--hydrogen Bromide (1/1)

2.4 Create Date
2007-01-10
3 Chemical and Physical Properties
Molecular Weight 320.65 g/mol
Molecular Formula C13H19BrClNO
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count2
Rotatable Bond Count4
Exact Mass319.03385 g/mol
Monoisotopic Mass319.03385 g/mol
Topological Polar Surface Area29.1 Ų
Heavy Atom Count17
Formal Charge0
Complexity247
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count1
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2
4 Drug and Medication Information
4.1 Drug Information
1 of 4  
Drug NameAplenzin
Active IngredientBupropion hydrobromide
Dosage FormTablet, extended release
RouteOral
Strength348mg; 522mg; 174mg
Market StatusPrescription
CompanyValeant Bermuda

2 of 4  
Drug NameBupropion hydrobromide
PubMed HealthBupropion (By mouth)
Drug ClassesAntidepressant, Smoking Cessation Agent
Active IngredientBupropion hydrobromide
Dosage FormTablet, extended release
Routeoral
Strength522mg; 174mg
Market StatusTentative Approval
CompanyWatson Labs

3 of 4  
Drug NameAplenzin
Active IngredientBupropion hydrobromide
Dosage FormTablet, extended release
RouteOral
Strength348mg; 522mg; 174mg
Market StatusPrescription
CompanyValeant Bermuda

4 of 4  
Drug NameBupropion hydrobromide
PubMed HealthBupropion (By mouth)
Drug ClassesAntidepressant, Smoking Cessation Agent
Active IngredientBupropion hydrobromide
Dosage FormTablet, extended release
Routeoral
Strength522mg; 174mg
Market StatusTentative Approval
CompanyWatson Labs

5 Pharmacology and Biochemistry
5.1 FDA Pharmacological Classification
5.1.1 Pharmacological Classes
Dopamine Uptake Inhibitors [MoA]; Increased Dopamine Activity [PE]; Increased Norepinephrine Activity [PE]; Norepinephrine Uptake Inhibitors [MoA]; Aminoketone [EPC]

API SUPPLIERS

read-more
read-more
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

API Reference Price

read-more
read-more
[{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1724783400,"product":"BUPROPION HYDROBROMIDE","address":"NO.2-22-311\/30C,SRI NILAYAM,BEHIND","city":"OPP KPHB CLY,KUKATPALLY,HYDERABAD.","supplier":"CHEMECA DRUGS PRIVATE ","supplierCountry":"INDIA","foreign_port":"NEW YORK - JOHN F. K","customer":"SCIEGEN PHARMACEUTICALS","customerCountry":"UNITED STATES","quantity":"661.50","actualQuantity":"661.5","unit":"KGS","unitRateFc":"200","totalValueFC":"126983.7","currency":"USD","unitRateINR":16101.601572184429,"date":"28-Aug-2024","totalValueINR":"10651209.44","totalValueInUsd":"126983.7","indian_port":"Hyderabad Air","hs_no":"29223900","bill_no":"3547730","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"NO.2-22-311\/30C,SRI NILAYAM,BEHIND, OPP KPHB CLY,KUKATPALLY,HYDERABAD.","customerAddress":""}]
28-Aug-2024
28-Aug-2024
KGS
overview
Loading...

Average Price (USD/KGS)

Number of Transactions

Total Quantity (KGS)

Total Value (USD)

Quantity (KGS) & Unit rate (USD/KGS) over time

API Imports and Exports

Importing Country Total Quantity
(KGS)
Average Price
(USD/KGS)
Number of Transactions

Upgrade, download data, analyse, strategize, subscribe with us contact

DRUG PRODUCT COMPOSITIONS

Do you need Business Intel? Ask us

DOSAGE - TABLET, EXTENDED RELEASE;ORAL - 174M...DOSAGE - TABLET, EXTENDED RELEASE;ORAL - 174MG

USFDA APPLICATION NUMBER - 22108

read-more

DOSAGE - TABLET, EXTENDED RELEASE;ORAL - 348M...DOSAGE - TABLET, EXTENDED RELEASE;ORAL - 348MG

USFDA APPLICATION NUMBER - 22108

read-more

DOSAGE - TABLET, EXTENDED RELEASE;ORAL - 522M...DOSAGE - TABLET, EXTENDED RELEASE;ORAL - 522MG

USFDA APPLICATION NUMBER - 22108

read-more

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Coating Systems & Additives

read-more
read-more

Disintegrants & Superdisintegrants

read-more
read-more

Controlled & Modified Release

read-more
read-more

Fillers, Diluents & Binders

read-more
read-more

Solubilizers

read-more
read-more

Granulation

read-more
read-more

Direct Compression

read-more
read-more

Topical

read-more
read-more

Thickeners and Stabilizers

read-more
read-more

Parenteral

read-more
read-more

Film Formers & Plasticizers

read-more
read-more

Chewable & Orodispersible Aids

read-more
read-more

Co-Processed Excipients

read-more
read-more

Taste Masking

read-more
read-more

API Stability Enhancers

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

DATA COMPILATION #PharmaFlow

read-more
read-more

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty